Academic history
Andrew Rawstron, MD, PhD, is a Clinical Scientist at the Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Speaking on MRD in CLL
Dr Rawstron’s primary research focus is on predicting suboptimal responses of patients with chronic lymphocytic leukemia (CLL) with tools such as measurable residual disease (MRD).
